Researcher
Christopher Cawthorne
- Disciplines:Medical imaging and therapy, Medicinal products
Affiliations
- Nuclear Medicine & Molecular Imaging (Division)
Member
From3 Sep 2018 → Today
Projects
1 - 7 of 7
- [18F]-MFBG PET of the cardiac noradrenergic system for early differentiation in Parkinson’s disease and dementia with Lewy bodies.From1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Flanders BioImaging: Leading Imaging Application Integrated Service and Enablement (FBI-LIAISE)From1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- Targeted alpha therapy of pancreatic tumors in a theranostic settingFrom1 Oct 2022 → TodayFunding: BOF - projects, Fund Recuperation Fiscal Exemption
- IMAGINATION : IMAGing bIomarkers for diagNosis, therAnosTIcs and drug develOpmeNtFrom1 Oct 2022 → TodayFunding: IOF - mandates
- "Dosimetry aspects of recoiling daughter nuclides of 225-Actinium in Targeted Alpha Therapy"From8 Nov 2019 → 15 Jul 2022Funding: SCK (Study Centre Nuclear Energy)
- Integrated image processing and electro-anatomical mapping to assess arrhythmogenicity of the infarct border zoneFrom4 Nov 2019 → 17 Nov 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- BEyOND: Brain pEt to Overcome Neurodegenerative Diseases.From15 Apr 2019 → 14 Apr 2021Funding: BOF - various
Publications
1 - 10 of 46
- Staying on track - Keeping things running in a high-end scientific imaging core facility(2024)
Authors: Christopher Cawthorne, Sebastian Munck
Pages: 276 - 294 - Innovating in a bioimaging core through instrument development(2024)
Authors: Sebastian Munck, Christopher Cawthorne
Pages: 319 - 337 - What we can learn from deep space communication for reproducible bioimaging and data analysis(2024)
Authors: Christopher Cawthorne, Sebastian Munck
Pages: 1 - 5 - Targeted STAT1 therapy for LZTR1-driven peripheral nerve sheath tumor(2023)
Authors: Christopher Cawthorne, Willy Gsell, Greetje Vande Velde, Christophe Deroose, Koen Van Laere, Uwe Himmelreich, Raj Sewduth, Anna Sablina
Pages: 1386 - 1390 - Synthesis and Preclinical Evaluation of PSMA-Targeted 111In-Radioconjugates Containing a Mitochondria-Tropic Triphenylphosphonium Carrier(2023)
Authors: Frederik Cleeren, Irwin Cassells, Simon Leekens, Christopher Cawthorne
Pages: 216 - 233 - In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4(2023)
Authors: Christopher Cawthorne
- Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist(2023)
Authors: Stephen Ahenkorah, Christopher Cawthorne, Christophe Deroose, Thomas Cardinaels, Guy Bormans, Frederik Cleeren
- Utilizing PET and MALDI Imaging for Discovery of a Targeted Probe for Brain Endocannabinoid α/β-Hydrolase Domain 6 (ABHD6)(2023)
Authors: Wim Vanduffel, Christopher Cawthorne, Sofie Celen, Guy Bormans
Pages: 538 - 552 - Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy(2022)
Authors: Christopher Cawthorne
Pages: 110 - 120 - 3p-C-NETA: A versatile and effective chelator for development of Al18F-labeled and therapeutic radiopharmaceuticals(2022)
Authors: Stephen Ahenkorah, Christopher Cawthorne, Christophe Deroose, Thomas Cardinaels, Willy Gsell, Guy Bormans, Frederik Cleeren
Pages: 5971 - 5985